Mifamurtide vs Thymopentin
Head-to-head comparison of Mifamurtide (Muramyl Tripeptide Phosphatidylethanolamine) and Thymopentin (L-Arginyl-L-Lysyl-L-Aspartyl-L-Valyl-L-Tyrosine) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Mifamurtide | Thymopentin |
|---|---|---|
| Category | Immune Support | Immune Support |
| Full Name | Muramyl Tripeptide Phosphatidylethanolamine | L-Arginyl-L-Lysyl-L-Aspartyl-L-Valyl-L-Tyrosine |
| Molecular Weight | N/A | 676.78 Da |
| Half-Life | 2-4 h | 10-30 min |
| Amino Acids | N/A | 5 |
| Typical Dose | 2 mg/m2 | 1 mg |
| Route | Intravenous | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 150 | 90 |
| Research Status | Clinical | Clinical |
Mifamurtide Benefits
- ✓macrophage-activation
- ✓innate-immune-signaling
- ✓immune-adjuvant-research
- ✓cytokine-response
Thymopentin Benefits
- ✓t-cell maturation
- ✓helper-suppressor balance
- ✓immune recovery
- ✓antiviral-adjunct research
Mifamurtide Dosing
2 mg/m2 IV|2x weekly for 12 weeks|then weekly for 24 weeks in approved regimens
Thymopentin Dosing
1 mg SC or IM|2-3x weekly|4-8 week study cycles
Mifamurtide Side Effects
- ⚠fever/chills
- ⚠fatigue
- ⚠nausea
Thymopentin Side Effects
- ⚠injection-site redness
- ⚠mild fever
- ⚠headache
Research Overview
Mifamurtide
Mifamurtide has substantial literature as an innate immune activator and is an approved oncology adjunct in some regions. Research centers on NOD-like receptor signaling, macrophage activation, and downstream cytokine effects.
Thymopentin
Thymopentin has a long history of preclinical and clinical investigation as a thymic peptide immunomodulator. Published studies report effects on T-cell subsets, cytokine responses, and immune recovery in recurrent infection settings.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.